ArticleCureus2026
Remote Adolescent-Onset Chorea Preceding Thrombotic Antiphospholipid Syndrome: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by vascular thrombosis and/or obstetric morbidity in the presence of persistent antiphospholipid antibodies. Chorea is an uncommon neurological manifestation, reported in approximately 1% of patients, and is not included among the clinical domains required for classification. We report the case of a 28-year-old woman who presented with acute left-sided sensorimotor deficits. Her only relevant history was an episode of chorea involving the left upper limb at 18 years of age, which resolved spontaneously after an incomplete etiological workup at another institution. Neuroimaging demonstrated a right frontal ischemic lesion, and cardioembolic and large-vessel causes were excluded. Prompted by the prior history of chorea, testing revealed persistently high-titer anticardiolipin IgG and anti-β2-glycoprotein I IgG antibodies, establishing a diagnosis of primary APS. She was started on warfarin and achieved functional independence without recurrent vascular events. This case illustrates that juvenile-onset chorea may represent the heralding manifestation of APS, preceding the qualifying thrombotic event by a decade. An isolated, self-limited chorea of undetermined cause should prompt antiphospholipid antibody testing, as early recognition may allow timely thromboprophylaxis and potentially prevent cerebrovascular events in young patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.